AstraZeneca to close its Montreal research centre as part of a global reorganization
Pharmaceutical company AstraZeneca is closing its Montreal research centre as part of a global reorganization of its research and development activities.
LONDON - Drugmaker AstraZeneca PLC says it is abandoning plans to develop a new anti-ovarian cancer drug and also says a planned antidepressant has underperformed in tests.